Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Treatment of precancerous anal growths in HIV patients decreases the progression to anal cancer

A team of researchers, including LSU Health New Orleans Infectious Diseases and Microbiology professor Michael Hagensee, MD, PhD, has shown for the first time that treating precancerous anal growths called high-grade squamous intraepithelial lesions (HSILs) in persons living with HIV significantly decreased the progression to anal cancer.

15 Jul 2022

Nomogram helps predict anal cancer risk in HIV patients

Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).

1 Jul 2022

Scientists create new fluorophores that could help fight cancer

Scientists from the Ural Federal University and the Ural Branch of the Russian Academy of Sciences have created new fluorescent chemical compounds (fluorophores) for photodynamic therapy of cancerous tumors, the latest method of treating cancer.

27 Jun 2022

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.

15 Jun 2022

Preventive care may be free, but follow-up diagnostic tests can bring big bills

When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting the test that told her she had breast cancer.

14 Jun 2022

Study offers a new and unique treatment for AIDS

A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for patients with HIV.

13 Jun 2022

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

The Centers for Disease Control and Prevention today announced first-year funding awards of $215 million in a 5-year, $1.1 billion investment into three national programs to prevent and control cancer.

10 Jun 2022

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Children (0-14 years) diagnosed with leukemia have benefited from decades of research to improve outcomes, and their five-year survival has increased more than that of adolescents (15-19 years) and young adults (20-24 years), suggests new research published in The Lancet Child and Adolescent Health.

6 Jun 2022

Study reveals significant decline in breast, cervical, colorectal cancer screenings due to COVID-19 pandemic

New findings led by researchers at the American Cancer Society (ACS) show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018.

3 Jun 2022

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

A new large national study led by researchers at the American Cancer Society shows the mortality risk from cardiovascular disease (CVD) differs considerably among cancer survivors by race/ethnicity and cancer types.

31 May 2022

Sexual minority individuals less likely to have undergone cervical cancer screening, study reveals

A recent database analysis reveals that in recent years, sexual minority individuals-; those whose sexual orientation differs from societal norms-; were less likely to have undergone cervical cancer screening tests than heterosexual counterparts, with Hispanic sexual minority individuals having the lowest screening rates.

16 May 2022

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020.

9 May 2022

£1.5 million funding to support new project using an at-home test to detect HPV

A new project using an at-home test to detect Human papillomavirus (HPV) is being trialed in Hull and Manchester, thanks to £1.5 million funding from the charity Yorkshire Cancer Research.

5 May 2022

Detailed estimates of cancer incidence, mortality and survival in Canada

Overall cancer rates in Canada are declining, but the number of cases and deaths are increasing slightly because of population growth and an aging population, according to a new study on cancer data published in CMAJ.

2 May 2022

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers at Ural Federal University have proposed the use of polyoxometallate nanoclusters as a carrier for chemotherapy drug. It will help to deliver medications precisely to the focus of a pathological process, such as a cancerous tumor, without toxic effects on healthy cells.

28 Apr 2022

Cervical Cancer News and Research

Further Reading

Treatment of precancerous anal growths in HIV patients decreases the progression to anal cancer

Nomogram helps predict anal cancer risk in HIV patients

Scientists create new fluorophores that could help fight cancer

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

Preventive care may be free, but follow-up diagnostic tests can bring big bills

Study offers a new and unique treatment for AIDS

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Study reveals significant decline in breast, cervical, colorectal cancer screenings due to COVID-19 pandemic

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

Sexual minority individuals less likely to have undergone cervical cancer screening, study reveals

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

£1.5 million funding to support new project using an at-home test to detect HPV

Detailed estimates of cancer incidence, mortality and survival in Canada

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

Researchers identify five types of bacteria in men with aggressive prostate cancer

Racism may partly contribute to high cancer burden impacting Asian Americans

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News